期刊文献+

^(18)F-FDG PET/CT诊断原发性肝癌和肝转移瘤的价值 被引量:27

Value of ^(18)F-FDG PET/CT in diagnosis of primary hepatocellular carcinoma and liver metastases
下载PDF
导出
摘要 目的探讨18F-FDG PET/CT在原发性肝癌和肝转移瘤诊断中的应用价值。方法回顾性分析108例肝脏肿瘤患者临床资料、常规影像(超声、增强CT和MRI)及PET/CT资料,病灶18F-FDG浓集水平高于周围正常肝组织为诊断恶性标准。结果 108例肝脏肿瘤各种影像检查共检出194个病灶,70个肝细胞癌病灶18 F-FDG PET/CT发现34个,最大标准摄取值(SUVmax)为4.95±3.86;23个胆管细胞癌病灶PET/CT发现22个,SUVmax为7.65±3.88;101个肝内转移瘤病灶PET/CT发现97个,SUVmax为9.65±5.34。18 F-FDG PET/CT对肝转移瘤和胆管细胞癌的阳性检出率(96.04%和95.65%)均高于肝细胞癌(48.57%),差异均有统计学意义(P均<0.05);肝转移瘤与肝细胞癌、胆管细胞癌与肝细胞癌之间SUVmax的差异均有统计学意义(P均<0.05)。不同原发肿瘤来源的肝转移灶的SUVmax值差异无统计学意义(F=2.07,P>0.05)。结论 18F-FDG PET/CT对原发性肝癌和肝转移瘤的病灶检出率不同,病灶的SUVmax值亦存在差异;在肝脏肿瘤诊断与分期时需科学合理应用18F-FDG PET/CT。 Objective To explore the application value of ^18F-FDG PET/CT in diagnosis of primary hepatocellular carcinoma and liver metastases.Methods The clinical results and imaging findings including ultrasound,enhancement CT,MRI and PET/CT of 108 patients with liver neoplasms were retrospectively analyzed.The malignant lesion was diagnosed when ^18F-FDG foci concentration level with the tumor was higher than the surrounding normal liver tissue.Results In 108 cases,a total of 194 lesions were detected by common imaging and PET/CT.Amongst 70 hepatocellular carcinomas(HCC),^18F-FDG PET/CT revealed 34 lesions,with the maximum standardized uptake value(SUVmax)was 4.95±3.86.18F-FDG PET/CT also revealed 22 of 23cholangiocellular carcinomas(CCC),with the SUVmaxof 7.65±3.88.And 97 cases of 101 liver metastatic lesions,with the SUVmaxof 9.65±5.34.The positive finding of live metastases and CCC undergoing 18F-FDG PET/CT(detection rates 96.04% and 95.65%)were higher than that of HCC(48.57%,both P〈0.05).The SUVmaxbetween liver metastases and HCC,CCC and HCC were significantly different(both P〈0.05),in addition,there was no significant difference among liver metastases derived from different primary tumors(F=2.07,P〉0.05).Conclusion ^18F-FDG PET/CT have different accuracies for detecting primary liver neoplasms and liver metastases,which are also with different SUVmax,it is necessary to be scientific and rational use of 18F-FDG PET/CT in the diagnosis and staging of liver neoplasms.
出处 《中国医学影像技术》 CSCD 北大核心 2015年第1期77-81,共5页 Chinese Journal of Medical Imaging Technology
关键词 肝肿瘤 肿瘤转移 正电子发射型体层摄影术 体层摄影术 X线计算机 18F氟脱氧葡萄糖 Liver neoplasms Neoplasm metastasis Positron-emission tomography Tomography X-ray computed Fluorodeoxyglucose F18
  • 相关文献

参考文献12

  • 1邢古生,王爽,欧阳汉,马霄虹,周纯武.CT与MRI增强扫描诊断肝细胞癌的对比分析[J].中国医学影像技术,2010,26(1):1-4. 被引量:25
  • 2Sharma B, Martin A, Zerizer I, et al. Positron emission tomo-graphy-computed tomography in liver imaging. Semin Ultrasound CT MR, 2013,34(1) :66-80.
  • 3Bohm B, Voth M, Geoghegan J, et aI. Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oneol, 2004,130(5) :266-272.
  • 4Talbot JN, Gutman F, Fartoux L, et al. PET/CT in patients with hepatocellular carcinoma using 1-(18) F3 Iluorocholine: Pre- liminary comparison with [(18) F] FDG PET/CT. Eur J Nucl Med Mol Imaging, 2006,33(11) : 1285-1289.
  • 5吴冰,韩磊,姜磊,陈曙光,顾宇参,石洪成.^18F-FDGPET/CT双时相显像在肝细胞肝癌诊断中的应用价值[J].中华核医学与分子影像杂志,2014,34(1):58-59. 被引量:23
  • 6Salem N, Kuang Y, Corn D, et al. [(Methyl)1-(11)c]-acetate metabolism in hepatocellular carcinoma. Mol Imaging Biol, 2011, 13(1) : 140-151.
  • 7Eckel F, Herrmann K, Schmidt S, et al. Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F fluorothy- midine. J Nucl Med, 2009,50(9) :1441-1447.
  • 8Petrowsky H, Wildbrett P, Husarik DB, et al. Impact of inte- grated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangio- carcinoma. J Hepatol, 2006,45(1) :43-50.
  • 9Paudyal B, Oriuchi N, Paudyal P, et al. Clinicopathological pres- entation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcino- ma and cholangiocellular carcinoma. Ann Nucl Med, 2008, 22 (1) :83-86.
  • 10Cameron K, Golan S, Simpson W, et al. Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose posi- tron emission tomography/computed tomography (PET/CT) Ahdom Imaging, 2011,36(4) :463-471.

二级参考文献22

  • 1Tian-Qi Liu,Jun Fan,Lin Zhou and Shu-Sen Zheng Key Laboratory of Combined Multi-organ Trans-plantation,Ministry of Public Health,Key Laboratory of Organ Trans-plantation,Zhejiang Province,and Division of Hepatobiliary and Pancreatic Surgery,Department of Surgery,State Key Laboratory for Diagnosis and Treatment of Infectious Disease,First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China,Department of Hepatobiliary Surgery,the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021,China.Effects of suppressing glucose transporter-1 by an antisense oligodeoxynucleotide on the growth of human hepatocellular carcinoma cells[J].Hepatobiliary & Pancreatic Diseases International,2011,10(1):72-77. 被引量:9
  • 2商健彪,李彦豪,刘方颖,王全师,曾庆乐,郭晓君,陈勇,吴湖炳.^(18)F-FDG PET显像在肝细胞癌介入治疗后残留病灶检出中的应用[J].中华核医学杂志,2004,24(6):325-327. 被引量:19
  • 3Robinson P. Hepatocellular carcinoma: development and early detection. Cancer Imaging, 2008,8(Suppl A) :S128-131.
  • 4Kim YK, Kim CS, Chung GH, et al. Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. AJR Am J Roentgenol, 2006,186 (1) :149-157.
  • 5Rode A, Bancel B, Douek P, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr, 2001,25(3) :327-336.
  • 6Sahani DV, Kalva SP. Imaging the liver. Oncologist, 2004,9(4): 385-397.
  • 7Secil M, Obuz F, Altay C, et al. The role of dynamic subtraction MRI in detection of hepatocellular carcinoma. Diagn Interv Radiol, 2008,14(4) :200-204.
  • 8Hecht EM, Holland AE, Israel GM, et al. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D Tl-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology, 2006,239(2) : 438-447.
  • 9Kim SJ, Kim SH, Lee J, et al. Ferucarbotran-enhanced 3.0-T magnetic resonance imaging using parallel imaging technique compared with triple-phase multideteetor row computed tomography for the preoperative detection of hepatocellular carcinoma. J Comput Assist Tomogr, 2008,32(3) : 379-385.
  • 10Willatt JM, Hussain HK, Adusumilli S, et al. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology, 2008,247(2):311-330.

共引文献46

同被引文献254

引证文献27

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部